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Abstract
Background: Medication adherence is an important but highly complex set of behaviors, which for life-threatening and infectious
diseases such as HIV carry critical consequences for individual and public health. There is growing evidence that mobile phone
text messaging interventions (mHealth) connecting providers with patients positively impact medication adherence, particularly
two-way engagement platforms that require bidirectional communication versus one-way in which responses are not mandatory.
However, mechanisms of action have not been well defined. The Behavior Change Wheel is a comprehensive framework for
behavior change that includes an all-encompassing model of behavior known as Capability Opportunity Motivation-Behavior
and is complemented by a taxonomy of behavior change techniques. Evaluating mHealth interventions for medication adherence
using these tools could provide useful insights that may contribute to optimizing their integration into the healthcare system and
successful scaling-up.
Objective: This study aimed to help address the current knowledge gap regarding how two-way mHealth interventions for
medication adherence may work by applying the Behavior Change Wheel to characterize WelTel: an interactive digital health
outreach platform with robust evidence for improving adherence to antiretroviral therapy.
Methods: To characterize how WelTel may promote medication adherence, we applied the Behavior Change Wheel to
systematically (1) generate a behavioral diagnosis through mapping known antiretroviral therapy adherence barriers onto the
Capability Opportunity Motivation-Behavior model of behavior, (2) specify the behavior change techniques that WelTel delivers,
(3) link identified behavior change techniques to corresponding intervention functions of the Behavior Change Wheel, and (4)
connect these behavior change techniques and intervention functions to respective Capability Opportunity Motivation-Behavior
influences on behavior to determine potential mechanisms of action.
Results: Our evaluation of WelTel using the Behavior Change Wheel suggests that most of its impact is delivered primarily
through its personalized communication component, in which 8 different behavior change techniques were identified and linked
with 5 intervention functions (environmental restructuring, enablement, education, persuasion, and training). Its mechanisms of
action in promoting antiretroviral therapy adherence may involve addressing all Capability Opportunity Motivation-Behavior
influences on behavior (physical and psychological capability, physical and social opportunity, reflective and automatic motivation).
Conclusions: Systematically unpacking the potential active ingredients of effective interventions facilitates the creation and
implementation of more parsimonious, tailored, and targeted approaches. Evaluating WelTel using the Behavior Change Wheel
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has provided valuable insights into how and why such interactive two-way mHealth interventions may produce greater impact
than one-way in addressing both nonintentional and intentional forms of nonadherence. The application of the Behavior Change
Wheel for evidence synthesis across mHealth interventions targeting various conditions would contribute to strengthening the
knowledge base regarding how they may work to impact medication adherence behavior.
(JMIR Mhealth Uhealth 2018;6(4):e87)   doi:10.2196/mhealth.9187
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Introduction
Medication Adherence Is a Significant Global
Challenge
In chronic disease management worldwide, only 50% of patients
on average adhere to their prescribed long-term therapies [1].
Medication adherence is an important, but highly complex set
of behaviors, which for life-threatening and infectious diseases
such as HIV carry critical consequences for individual and
public health. Adherence to antiretroviral therapy (ART) for
people living with HIV combats chronic infection through viral
suppression, optimizes an individual’s immune recovery,
mitigates drug resistance, and reduces odds of viral transmission
[2-4]. Viral suppression achieved through adherence is essential
for achieving global “90-90-90” targets declared by the Joint
United Nations Programme on HIV/AIDS: by 2020, 90% of all
people living with HIV will know their status, 90% of all people
diagnosed as HIV-positive will receive uninterrupted ART, and
90% of all people taking ART will achieve viral suppression
[5]. However, suboptimal ART adherence is not uncommon,
and realizing the full benefits of ART requires considerable
effort for many [6]. Concerted efforts over the past two decades
have been geared toward specifying effective interventions for
ART adherence globally [6,7]; however, efforts to distil active
intervention ingredients remain largely absent. Given that
medication adherence is often subject to multilevel influences
beyond the individual, investigating mechanisms of action
through which interventions may promote this behavior
facilitates the delivery of systematically created and targeted
approaches. Understanding and specifying the potential
underlying mechanisms behind effective interventions is critical
for design improvement and successful wide-scale
implementation.
Certain mHealth Interventions may Offer a Solution
Mobile phone interventions for promoting health (mHealth) are
becoming increasingly available, and several interventions aim
to improve medication adherence across various disease states
[8,9]. Among people living with HIV, the World Health
Organization recognizes text messaging in their current
guidelines as an evidence-based intervention for encouraging
ART adherence [10]. However, no distinction has been made
between the various types of applications that exist. In particular,
two-way versus one-way engagement platforms are significantly
different from each other; the former implies an expectation of
patient-provider communication, whereas the latter simply
prompts reminders and instructions without mandatory patient
feedback. Two-way text messaging is thought to be more
effective compared with one-way for inducing ART adherence,
and this distinction has important implications on the usage of
text messaging for chronic disease management [9,11]. Policy
makers in control of health care expenditure may attempt to
promote cost saving through spacing clinic visits further apart;
therefore, interactive mHealth interventions potentially offer
cost-effective and essential touch points between these visits to
keep patients engaged in care [12]. In addition, they may prompt
the self-management of issues as they occur in a timely manner.
Furthermore, such interventions can benefit both patients and
health care providers in more resource-limited contexts through
addressing demand-side and supply-side challenges that exist
in service delivery. Interactive two-way mHealth engagement
can help alleviate such health care system strain and improve
its efficiency through focusing on patients who are in the most
need of care at any given time, while promoting the
individualized downstream care pathway that may include
tailored patient-provider communication beyond text messaging.
Ambiguity Exists Today Regarding how mHealth
Interventions for Medication Adherence Work
Although there is growing quantitative evidence that two-way
text messaging is superior to one-way for improving medication
adherence, there remains a significant knowledge gap as to why.
Mechanisms of action behind these interventions are currently
unspecified. Consequently, this lack of insight may contribute
to future challenges with regard to integrating such interventions
into health services, and ultimately scaling them up. Attaining
strong foundational knowledge of how the intervention
influences adherence behavior may contribute to maximizing
implementation success. In the context of HIV, similar
sentiments have been shared in a systematic review focused on
unpacking group-based ART adherence interventions to describe
how they may work [13].
WelTel is an example of an interactive two-way mHealth
intervention that has been shown to improve self-reported 95%
ART adherence and viral load suppression rates, as demonstrated
by a multisite randomized clinical trial conducted in Kenya [14]
and further validated in Canada [15]. Delivery of the digital
health outreach platform included a weekly automated text
message saying “How are you?” (“Mambo?” in Kiswahili), and
the patient was obliged to respond accordingly. If the patient
replied “problem” (“Shida” in Kiswahili) or was unresponsive,
a care provider initiated a follow-up and personalized care was
given.
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Figure 1. Behavior Change Wheel (image spelling has been modified, based on Michie S et al [18]).
Figure 2. Capability Opportunity Motivation - Behavior (COM-B) model of behavior (image spelling has been modified, based on Michie S et al [18]).
Objective
The primary objective of this study was to investigate and
specify WelTel’s potential mechanisms of action using a
comprehensive and evidence-based theory of behavior change
framework. The Behavior Change Wheel (BCW) (Figure 1)
provides a systematic approach to designing and evaluating
interventions, and has been developed through the synthesis of
19 existing behavior change frameworks [16]. It characterizes
an array of intervention functions (broad strategies for inducing
the target behavior) and policy functions (ways to support and
implement these strategies) that can be used within a wide range
of contexts. Specifying linkages between intervention functions
and influences on the target behavior reveals appropriate
strategies for potentially bringing upon change [16]. A
complementary behavior change taxonomy further elaborates
upon these intervention functions in terms of many specific
behavior change techniques (BCTs) [17]. Moreover, the BCW
highlights the importance of taking into account multilevel
influences on behavior through incorporation of the Capability
Opportunity Motivation-Behavior (COM-B) model of behavior
(Figure 2).
Using WelTel as a case study, our goal was to help address the
current research gap regarding the qualitative evidence of
two-way mHealth interventions for improving medication
adherence.
Methods
In our evaluation of WelTel using the BCW and its
complementary taxonomy of BCTs, 4 steps were required to
systematically determine the intervention’s potential mechanisms
of action for improving medication adherence (Figure 3).
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Figure 3. Determining potential mechanisms of action of an intervention using the Behavior Change Wheel (BCW).
Step 1: Identify Barriers to Medication Adherence
Using the Capability Opportunity Motivation-Behavior
(COM-B) Model of Behavior
A behavioral diagnosis of ART nonadherence was formulated
through the application of the COM-B model of behavior.
Known barriers to ART adherence that exist within various
countries have been specified in a systematic review [2]. Nine
of them considered to be globally relevant were chosen and
mapped onto COM-B to reveal influences on behavior that are
potentially associated with nonadherence. This process enabled
us to gain insight into what needs to change for the target
behavior of adherence to occur.
The COM-B model of behavior comprises the core of the BCW,
encompassing capability, opportunity, and motivation as the
influences on behavior, illustrating the potential interactions
between them and the resultant behavior [16]. According to this
theory, capability, opportunity, and motivation all need to be
present for any behavior to occur, and each component can
influence it independently of one another as well as
synergistically [18]. Capability is related to one having the
psychological (required knowledge and skills) and physical
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capacity to engage in the behavior. Opportunity is divided into
physical (associated with the external environment) and social
(ie, cultural norms and interpersonal influences) factors that
promote or impede behavior within the individual [16].
Motivation encompasses all brain activity that provokes
behavior, including automatic (ie, emotions, wants and needs,
and habits) and reflective (ie, belief systems, plans, and
evaluations) processes [16].
Step 2: Specify the Behavior Change Techniques of
the Intervention
BCTs delivered by WelTel were characterized using the BCT
taxonomy version 1 (BCTTv1). A BCT has been defined as an
“observable, replicable, and irreducible component of an
intervention designed to change behaviour and a postulated
active ingredient within the intervention” [18]. An intervention
protocol or manual is typically reviewed to provide the most
elaborate description of what it entails. In our evaluation, the
WelTel system’s user manual was chosen for analysis, as it
provides the most detailed information about the intervention.
Furthermore, BCT identification occurred through
semistructured discussions within a study team including key
stakeholders who have previously collected user feedback from
the WelTel platform. During the process of specifying BCTs,
all discrepancies were resolved by consensus.
The BCTTv1 serves to characterize an array of behavior change
interventions using a standardized language [17]. In the
evaluation of established interventions, their delivered content
can be specified, synthesized, and linked to the BCW to reveal
their intervention functions in order to provide insight into
possible active ingredients and mechanisms of action [17]. Upon
application, the relationships between the specified BCTs and
intervention effectiveness can be investigated; the BCTs that
may or may not be effective at changing behavior in addition
to other ones not currently being delivered by the intervention
have the potential to become identified.
Step 3: Link Identified Behavior Change Techniques
to Their Intervention Functions
Identified BCTs were connected with their respective
intervention functions, or broad strategies for bringing upon
behavior change, as characterized by the BCW. This process
was directed by guidelines provided by the creators of the BCW
(Multimedia Appendix 1) that list the BCTs associated with
each of the 9 intervention functions.
Step 4: Link Identified Behavior Change Techniques
and Respective Intervention Functions to Influences
on Behavior to Specify Potential Mechanisms of Action
To specify potential mechanisms of action, identified BCTs and
respective intervention functions were connected to influences
on behavior according to the COM-B model (capability,
opportunity, and motivation). We followed guidelines provided
by the creators of the BCW (Multimedia Appendix 1) that link
intervention functions to COM-B influences on behavior; only
those thought to be relevant to our study context were included.
Results
Step 1: Identify Barriers to Medication Adherence
Using the Capability Opportunity Motivation-Behavior
(COM-B) Model of Behavior
Formulating a behavioral diagnosis (Multimedia Appendix 2)
by mapping out 9 known globally relevant ART adherence
barriers onto the COM-B model has revealed that all influences
on behavior (physical and psychological capability, physical
and social opportunity, and automatic and reflective motivation)
may be associated with ART nonadherence, validating the notion
that bringing upon this change in behavior is highly complex.
The majority of these barriers were linked to more than one
COM-B influence on behavior, with reflective motivation and
automatic motivation being the most recurring. This implies
that both intentional and unintentional forms of nonadherence
commonly co-exist within the general adult population.
Furthermore, barriers related to a lack of social opportunity (ie,
fear of revealing HIV status to family/friends because of stigma
and competing priorities) may be appropriately mapped out
onto both reflective and automatic motivation. This suggests
that facilitating social opportunity could also promote the latter
COM-B influences on behavior simultaneously, and this
association could even contribute to inducing ART adherence
synergistically.
Step 2: Specify the Behavior Change Techniques of
the Intervention
Upon coding the WelTel manual using the BCTTv1 (Multimedia
Appendix 3), one BCT was identified for the intervention’s
automated text message component and specified as a
prompt/cue. In contrast, 8 different BCTs were identified for
its personalized communication component delivered in response
to receiving patient feedback of a problem. These were specified
as follows: (1) prompt/cue, (2) unspecified social support, (3)
reduce negative emotions, (4) credible source, (5) natural
consequences, (6) emotional social support, (7) practical social
support, and (8) instruction on how to perform a behavior.
Step 3: Link Identified Behavior Change Techniques
to Their Intervention Functions
The one BCT identified for WelTel’s automated text message
component was linked to one intervention function
(environmental restructuring; Multimedia Appendix 3). In
contrast, the 8 BCTs identified for its personalized
communication component were linked to 5 intervention
functions (environmental restructuring, enablement, education,
persuasion, and training; Multimedia Appendix 3).
Although the latter component of the intervention appears to
be more comprehensive, each of its intervention functions (broad
strategies for bringing upon behavior change) can be elaborated
upon in terms of several other different BCTs that were not
identified in our evaluation (Multimedia Appendix 1).
Furthermore, no BCTs were linked to other intervention
functions characterized by the BCW (specifically incentivization,
coercion, and modeling). These types of strategies may also be
ones to consider given the complexity of ART adherence, as
demonstrated by the behavioral diagnosis generated in this study
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(Multimedia Appendix 2). This suggests that the design of the
current intervention could be modified accordingly to potentially
have a greater impact on ART adherence.
Step 4: Link Identified Behavior Change Techniques
and Respective Intervention Functions to Influences
on Behavior to Specify Potential Mechanisms of Action
On the basis of our evaluation, WelTel’s potential mechanisms
of action in promoting ART adherence have been specified as
the intervention’s ability to: (1) influence one’s opportunity
(both physical and social) and automatic motivation through
environmental restructuring and enablement: the delivery of an
external trigger, as well as social support, to facilitate adherence
behavior; and (2) influence one’s capability (both physical and
psychological), opportunity (both physical and social), and
motivation (both automatic and reflective) through education,
persuasion, training, and enablement: the delivery of
health-related information and social support to facilitate
adherence behavior.
Discussion
Contribution to Behavioral Science Research
In the light of the current literature, this is the first paper to
demonstrate how a comprehensive and evidence-based behavior
change framework can be applied to an existing two-way
mHealth intervention. WelTel has robust evidence for improving
ART adherence [19]; therefore, it serves as an optimal means
for evaluation using the BCW, an all-encompassing theory that
can be appropriately applied worldwide [18]. Our evaluation
has systematically revealed its potential mechanisms of action
in addressing all influences on behavior regarding ART
adherence. This has been specified by the COM-B model of
behavior that encourages the critical multilayer examination of
the behavior at the individual, interpersonal, and system levels,
whereas other established behavioral theories may potentially
miss important drivers as not all of these levels of influence are
considered.
One-Way Versus Two-Way mHealth Intervention
Strategies: Distinguishing Between Them With Regard
to Targeting Nonintentional Nonadherence and
Intentional Nonadherence
The application of COM-B highlights the important differences
between unintentional and intentional medication nonadherence
with regard to their influences on behavior [20,21]. In the
context of taking ART daily, unintentional medication
nonadherence is often considered simply forgetting to perform
the behavior. This factor is related to one’s automatic
motivation, described as “processes involving emotional
responses, desires (wants and needs), impulses and reflex
responses” [18]. In contrast, intentional nonadherence is related
to purposeful deviation of the behavior that is associated with
reflective motivation, defined as “involving self-conscious
planning and evaluations (beliefs about what is good or bad)”
[18]. Although they stem from different sources of motivation,
both forms of nonadherence are not mutually exclusive from
each other, and thus often exist in any one individual prescribed
chronic disease treatment (such as ART) over the course of
treatment [22,23]. This reality emphasizes the need for
adherence-promoting strategies that are multifaceted and target
different COM-B influences of behavior.
The distinction between nonintentional and intentional
medication adherence behavior is important to consider
designing and evaluating interventions. It can provide an
explanation as to why interventions solely focused on
self-prompting and one-way medication reminders often have
failed to show significant impact in clinical trials. This lack of
effect has been shown in a randomized control trial using an
alarm device for promoting ART adherence [24], in addition to
a systematic review evaluating technology-based self-care
strategies for improving ART adherence [25]. Moreover, in a
systematic review of various mobile technology-based
interventions across chronic disease states beyond HIV (ie,
diabetes and hypertension), it has been implied that simple text
message reminders on their own have modest benefits for
influencing adherence [26]. The application of the BCTTv1 for
the purpose of evaluating such interventions would likely reveal
that the primary BCT being delivered by them is a prompt/cue
linked appropriately with the intervention function
environmental restructuring. Connecting this specification with
COM-B would indicate that this particular function likely has
the potential to only influence one’s physical opportunity
(providing a trigger to perform the behavior) and automatic
motivation (habit formation through reflex response). Limited
effects on other influences on behavior relating to adherence
would be expected, including the intervention’s ability to impact
one’s reflective motivation, psychological capability, and social
opportunity. Therefore, one-way reminder-based interventions
may bring upon behavior change with regard to nonintentional
nonadherence, but they are unlikely to influence intentional
nonadherence. This has been echoed in a meta-analysis
comparing one-way versus two-way text message interventions
for medication adherence across disease states [9].
Furthermore, it is useful to distinguish between simple two-way
text messaging and more complex interactive two-way
communication that provides open-ended, enhanced follow-up
support tailored to patients’ needs [27]. The former is only one
component of the WelTel intervention; however, a recent
network meta-analysis that evaluated all types of interventions
for HIV adherence globally has classified WelTel as a short
messaging service (text message) intervention only [6]. An
in-depth analysis of WelTel has revealed a comprehensive blend
of mechanisms behind its digital health outreach platform for
promoting ART adherence, thus differentiating itself from other
mHealth applications considered one-way in nature and other
forms of two-way communication that provide a relatively low
degree of social support and personalized care. Through
consistent weekly automated text messaging and subsequent
provider follow-up by phone if patients report a problem or are
nonresponsive, WelTel is postulated to deliver a variety of BCTs
that comprehensively induces ART adherence. The automated
text message component of the intervention is hypothesized to
primarily influence one’s physical opportunity and automatic
motivation. More importantly, the personalized, interactive
patient-provider communication component may have the
potential to impact all influences on behavior (physical and
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psychological capability, social and physical opportunity, and
reflective and automatic motivation). Through application of
the science of behavior change, we have been able to strengthen
the qualitative evidence base for how interactive two-way
mHealth interventions may impact both nonintentional and
intentional nonadherence.
Limitations of Our Evaluation Using the Behavior
Change Wheel
There were several limitations in using the BCW to evaluate
the mHealth intervention. First, coding of an intervention is
limited by its documented description (ie, an intervention
protocol or manual). Although this method promotes
transparency and data validation by external reviewers,
information about what the intervention delivers in terms of
BCTs may not be captured to its entirety. For example,
encouraging self-monitoring and goal setting could potentially
be BCTs delivered independently by the provider upon patient
follow-up using the WelTel platform. Evaluating a detailed
provider-patient communication log could help determine the
presence of such BCTs, and thus contribute to further specifying
WelTel’s behavior change mechanisms.
Second, using the BCTTv1 to characterize the mHealth
intervention resulted in some ambiguity because of its varied
interpretation. In our evaluation, we were uncertain whether or
not to code its automated text message component (“Mambo?”
or “How are you?”) as a prompt/cue and unspecified social
support, or solely the former. Given WelTel’s personalized
communication component for delivering tailored individual
care, we decided whatever social support that may be conveyed
in the automated text message component would be relatively
insignificant. Authors of an mHealth intervention evaluation
for smoking cessation have expressed similar sentiments, given
the brevity of its text message content and consequently less
meaning to draw upon [28]. To address limitations of the
taxonomy, one suggestion has been to modify the BCTTv1 for
mobile technology–based interventions as opposed to using a
generalized classification system for all types of behavioral
interventions [26].
Third, behavior change outcomes depend heavily on the
patient-provider relationship, which the BCW is unable to
account for. Interventions (for medication adherence and
retention in care) that prioritize patient confidentiality of HIV
status and promote the development of trusting relationships
would reduce barriers to their implementation [29,30]. The
benefits of personalized care have been echoed in [31] and
highlighted in a meta-analysis examining one-way and two-way
mHealth interventions for promoting ART adherence [11].
Regular two-way interaction allows for more opportunity to
build rapport; therefore, the presence of relatively strong social
support (greater enablement) through patient-provider
communication by phone would be postulated to enhance the
delivery of the BCTs specified in our evaluation.
Overall, the BCW can help to specify what the intervention
delivers in terms of content; however, more research is needed
to gain a better understanding of other intervention dimensions
that play a role in influencing medication adherence (ie, who
delivers it, messaging frequency), and how respective processes
of change may occur. Another consideration is the behavioral
facilitators and barriers that may exist with regard to using the
intervention itself. Identifying influences on user engagement
with WelTel may elucidate facilitators and barriers at the patient
and provider levels, such as comfort level with using the
technology and the provider’s style of communication, in
addition to knowledge base. It would be wise to identify
significant user facilitators and barriers before scaling up the
intervention to further optimize its integration into the health
care system. The importance of describing user feedback has
been emphasized in the mHealth evidence reporting and
assessment (mERA) checklist: recent guidelines that have been
created to improve the quality of evidence for mHealth through
providing a comprehensive and standardized way to report these
interventions [32].
Generalizability of Our Findings
Although WelTel’s digital outreach strategy is thought to address
ART adherence more comprehensively than one-way text
message engagement platforms, it cannot be assumed that its
proposed mechanisms of action would translate across all
HIV-positive populations worldwide. A systematic review
examining various ART adherence interventions have concluded
that behavioral interventions producing a positive impact in one
setting may not translate to other populations because of
differences in economic, social, and behavioral barriers to
adherence [33]. Such barriers including poverty and mental
health comorbidities commonly co-exist in various contexts,
and addressing these issues through respective integrative
services alongside public health HIV interventions may increase
implementation success of the latter [34].
Furthermore, it is uncertain if WelTel’s proposed mechanisms
of action are generalizable across other chronic disease states.
Beyond aiming to promote ART adherence globally and within
different populations [13,14,35], WelTel is currently being
tested and evaluated for impact on HIV retention in care [36-38],
in addition to medication adherence behaviors across other
health conditions such as tuberculosis and asthma [39-41].
Arguably, interventions based on a thorough understanding of
its target behavior in context will have greater potential for
impact. Upon specifying the underlying mechanisms of
medication adherence and nonadherence in a given environment,
it may be possible to map out the potential value of a WelTel
approach. In addition, the mechanisms of action of the
intervention may vary by context, and thus the expansion of
WelTel to other chronic conditions (as well as target behaviors
beyond medication adherence) will require future validation
work.
Implications for Future Research: Our Call to Action
It has been emphasized that replication, implementation, and
evidence synthesis are required to gain a more in-depth
understanding of behavior change mechanisms and to establish
a growing qualitative knowledge base for informing the
development of interventions that have greater impact [17]. We
hope that our evaluation of the WelTel mHealth service using
the BCW is repeated in a similar manner by other researchers
involved with mHealth interventions for promoting medication
adherence across various disease states and populations. Given
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the BCW’s established common language of behavior change
across interventions, such widespread application of the
framework would serve to identify the commonalities and
differences between their postulated effects, or lack of. Repeated
application would eventually serve to synthesize the current
evidence in a systematic manner, and help build a stronger
foundation as it relates to specifying how and which combination
of BCTs likely have a positive impact, and which ones have
minimal influence on medication adherence. With this collective
insight, the design of mHealth interventions could be modified
accordingly to improve population health outcomes.
Conclusions
Imposing the BCW onto WelTel has systematically revealed
its potential mechanisms of action for improving ART
adherence, while deepening our understanding that it may
address all influences of this behavior: capability (physical and
psychological), opportunity (physical and social), and motivation
(reflective and automatic). Our evaluation has revealed that
interactive, two-way mHealth interventions may deliver a
combination of BCTs that are more likely to capture this to its
entirety compared with one-way mHealth interventions, which
may only affect automatic motivation and physical opportunity.
This has strengthened the evidence base for how and why a
two-way design may be more effective than a one-way design
at addressing both nonintentional and intentional forms of
nonadherence. The application of the BCW for evidence
synthesis across mHealth interventions targeting various chronic
diseases would contribute to strengthening the knowledge base
regarding how they may work to impact medication adherence
behavior.
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